Association of CNS demyelination and COVID-19 infection: an updated systematic review Ismail Ibrahim IsmailSara Salama Review 12 August 2021 Pages: 541 - 576
A rise in cases of nitrous oxide abuse: neurological complications and biological findings Maximilian EinsiedlerPaul VoulleminotKévin Bigaut Original Communication 10 July 2021 Pages: 577 - 582
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination Mathias FousseDavid SchubJoão Reinoldo Goi Júnior Original Communication Open access 05 October 2021 Pages: 583 - 586
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study Alex Buoite StellaGiovanni FurlanisPaolo Manganotti Original Communication Open access 12 August 2021 Pages: 587 - 596
Decrease in intravenous thrombolysis and poor short-term functional prognosis for acute ischemic stroke during the COVID-19 pandemic Xueqian XuYuenan XiaoXiaoqian Luan Original Communication 11 August 2021 Pages: 597 - 602
Delays in thrombolysis during COVID-19 are associated with worse neurological outcomes: the Society of Vascular and Interventional Neurology Multicenter Collaboration Dinesh V. JillellaFadi NahabJames E. Siegler Short Commentary 31 July 2021 Pages: 603 - 608
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity Umberto PensatoGiulia AmoreMaria Guarino Short Commentary 23 August 2021 Pages: 609 - 615
Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events C. O´SullivanF. ZachP. Wipfler Letter to the Editors 24 July 2021 Pages: 616 - 618
Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis Seong-Hae JeongSun-Uk LeeJi-Soo Kim Review 07 August 2020 Pages: 619 - 626
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines Arturo NuaraMaddalena Fabbri-DestroPietro Avanzini Review 15 January 2021 Pages: 627 - 638
Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities Rotem Iris OradTamara Shiner Review 29 January 2021 Pages: 639 - 653
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap Dennis WalzlAndrew J. SolomonJon Stone Review Open access 21 February 2021 Pages: 654 - 663
Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials Tingting WuChenyang LvJinhua Zhang Review 17 February 2021 Pages: 664 - 675
Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review Ashley CrookChris JacobsAlison McEwen Review 01 March 2021 Pages: 676 - 692
Coping strategies among amyotrophic lateral sclerosis (ALS) patients: an integrative review Georgiana Soares LeandroMário Emílio Teixeira Dourado JúniorLuan Samy Xavier Dantas Review 30 March 2021 Pages: 693 - 702
Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis Rui ZhongQingling ChenWeihong Lin Review 22 February 2021 Pages: 703 - 711
Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review Judith N. WagnerAnnette LeibetsederTim J. von Oertzen Review Open access 06 March 2021 Pages: 712 - 724
Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder? Svetlana Blitshteyn Review 07 March 2021 Pages: 725 - 732
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis Berli SarahBrandi GiovannaPagnamenta Alberto Review Open access 13 April 2021 Pages: 733 - 741
A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION project Daniel C. DudmanFatima TauqeerSandra Lopez-Leon Review 01 April 2021 Pages: 742 - 749
Opsoclonus–myoclonus–ataxia syndrome in children Poonam BhatiaJennifer HeimMichael C. Kruer Review 29 March 2021 Pages: 750 - 757
Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT Balestrino RobertaBarone PaoloErro Roberto Review 18 September 2021 Pages: 758 - 770
Correction to: Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT Roberta BalestrinoPaolo BaroneRoberto Erro Correction 09 December 2021 Pages: 771 - 771
Safety and outcome of mechanical thrombectomy in ischaemic stroke related to carotid artery dissection A. KaramN. BricoutB. Casolla Original Communication 29 June 2021 Pages: 772 - 779
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease Michal LubomskiXiangnan XuRyan L. Davis Original Communication 15 June 2021 Pages: 780 - 795
What happens after fingolimod discontinuation? A multicentre real-life experience Doriana LandiAlessio SignoriJessica Frau Original Communication 16 June 2021 Pages: 796 - 804
Mitochondrial genome variations are associated with amyotrophic lateral sclerosis in patients from mainland China Jie NiZhen LiuJunling Wang Original Communication 15 June 2021 Pages: 805 - 814
Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases Xinqing LinTingting LuChengzhi Zhou Original Communication 20 July 2021 Pages: 815 - 823
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients Ilkka RaumaTiina MustonenHanna Kuusisto Original Communication Open access 13 July 2021 Pages: 824 - 835
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand Wajih BukhariElham KhalilidehkordiThe Australian and New Zealand NMO Collaboration Original Communication 02 July 2021 Pages: 836 - 845
Optimizing the selection of Parkinson’s disease patients for neuromodulation using the levodopa challenge test Dinkar KulshreshthaMarcus PietermanMandar Jog Original Communication 30 June 2021 Pages: 846 - 852
Paradigm shift in acute dizziness: is caloric testing obsolete? Miranda MorrisonAthanasia KordaGeorgios Mantokoudis Original Communication Open access 30 June 2021 Pages: 853 - 860
Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018 Mirketa MarkuBirthe Krogh RasmussenPernille Envold Bidstrup Original Communication 24 June 2021 Pages: 861 - 872
Traumatic brain injury fast-forwards Alzheimer’s pathology: evidence from amyloid positron emission tomorgraphy imaging Abdalla Z. MohamedPeter J. Nestorfor the Alzheimer’s Disease Neuroimaging Initiative Original Communication 30 June 2021 Pages: 873 - 884
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis Hitoshi AizawaHaruhisa KatoShin Kwak Original Communication Open access 30 June 2021 Pages: 885 - 896
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura Claudia AltamuraAngelo Cascio RizzoFabrizio Vernieri Original Communication 24 June 2021 Pages: 897 - 906
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP Emanuele SpinaPietro Emiliano DonedduThe Italian CIDP Database Study Group Original Communication Open access 26 June 2021 Pages: 907 - 912
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study K. HänninenM. ViitalaM. Soilu-Hänninen Original Communication Open access 25 June 2021 Pages: 913 - 922
Quantitative sensory testing and norepinephrine levels in REM sleep behaviour disorder – a clue to early peripheral autonomic and sensory dysfunction? Julia KochKira WillemsenAndrea Maier Original Communication Open access 25 June 2021 Pages: 923 - 932
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study Clara G. ChisariGiancarlo Comithe Italian MS Register Study Group. Original Communication 28 June 2021 Pages: 933 - 944
Clinical outcome of CIDP one year after start of treatment: a prospective cohort study S. R. M. BusM. C. Broersfor the ICOS Consortium Original Communication Open access 26 June 2021 Pages: 945 - 955
Initiation of antidepressants in young adults after ischemic stroke: a registry-based follow-up study Jenna BromanKaroliina AarnioJukka Putaala Original Communication Open access 24 June 2021 Pages: 956 - 965
Cystatin C predicts futile recanalization in patients with acute ischemic stroke after endovascular treatment Mouxiao SuYing ZhouGelin Xu Original Communication 05 July 2021 Pages: 966 - 972
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients Timo VolkKlaus WarnatzSebastian Rauer Original Communication Open access 01 July 2021 Pages: 973 - 981
Diagnosis and follow-up evaluation of central nervous system vasculitis: an evaluation of vessel-wall MRI findings Maximilian PatzigRobert ForbrigFlorian Schöberl Original Communication Open access 08 July 2021 Pages: 982 - 996
The angiographic presentation of European Moyamoya angiopathy Sara Pilgram-PastorRené ChapotMarkus Kraemer Original Communication Open access 08 July 2021 Pages: 997 - 1006
Blink reflex recovery cycle distinguishes patients with idiopathic normal pressure hydrocephalus from elderly subjects Alessandro MechelliAndrea QuattroneAldo Quattrone Original Communication 02 July 2021 Pages: 1007 - 1012
Association of the Careggi Collateral Score with 3-month modified Rankin Scale score after thrombectomy for stroke with occlusion of the middle cerebral artery Manuel CappellariValentina SaiaThe IRETAS Group Original Communication 19 November 2021 Pages: 1013 - 1023
Correction to: Association of the Careggi Collateral Score with 3-month modified Rankin Scale score after thrombectomy for stroke with occlusion of the middle cerebral artery Manuel CappellariValentina SaiaThe IRETAS Group Correction 24 December 2021 Pages: 1024 - 1025
Ocular flutter is a rare and treatment-responsive symptom in Lyme neuroborreliosis: a case report Fiona JägerStefan GreiseneggerGerald Wiest Letter to the Editors 28 August 2021 Pages: 1026 - 1027